Orosz G - Search Results

1

The effect of peptide length on the cleavage kinetics of 2-chlorotrityl resin-bound ethers.

Kocsis L, Ruff F, Orosz G. Kocsis L, et al. Among authors: orosz g. J Pept Sci. 2006 Jun;12(6):428-36. doi: 10.1002/psc.745. J Pept Sci. 2006. PMID: 16485312

2

Nociceptin antagonism: probing the receptor by N-acetyl oligopeptides.

Kocsis L, Orosz G, Magyar A, Al-Khrasani M, Kató E, Rónai AZ, Bes B, Meunier JC, Gündüz O, Tóth G, Borsodi A, Benyhe S. Kocsis L, et al. Among authors: orosz g. Regul Pept. 2004 Nov 15;122(3):199-207. doi: 10.1016/j.regpep.2004.06.019. Regul Pept. 2004. PMID: 15491792

3

Endomorphin synthesis in rat brain from intracerebroventricularly injected [3H]-Tyr-Pro: a possible biosynthetic route for endomorphins.

Rónai AZ, Szemenyei E, Kató E, Kocsis L, Orosz G, Al-Khrasani M, Tóth G. Rónai AZ, et al. Among authors: orosz g. Regul Pept. 2006 Mar 15;134(1):54-60. doi: 10.1016/j.regpep.2005.12.004. Epub 2006 Feb 7. Regul Pept. 2006. PMID: 16464510

4

In vitro binding and functional studies of Ac-RYYRIK-ol and its derivatives, novel partial agonists of the nociceptin/orphanin F/Q receptor.

Gunduz O, Sipos F, Spagnolo B, Kocsis L, Magyar A, Orosz G, Borsodi A, Calò G, Benyhe S. Gunduz O, et al. Among authors: orosz g. Neurosignals. 2006-2007;15(2):91-101. doi: 10.1159/000094743. Epub 2006 Jul 26. Neurosignals. 2006. PMID: 16874009 Free article.

5

Partial and full agonism in endomorphin derivatives: comparison by null and operational model.

Rónai AZ, Al-Khrasani M, Benyhe S, Lengyel I, Kocsis L, Orosz G, Tóth G, Kató E, Tóthfalusi L. Rónai AZ, et al. Among authors: orosz g. Peptides. 2006 Jun;27(6):1507-13. doi: 10.1016/j.peptides.2005.12.003. Epub 2006 Jan 18. Peptides. 2006. PMID: 16413634

6

Receptor constants for endomorphin-1 and endomorphin-1-ol indicate differences in efficacy and receptor occupancy.

Al-Khrasani M, Orosz G, Kocsis L, Farkas V, Magyar A, Lengyel I, Benyhe S, Borsodi A, Rónai AZ. Al-Khrasani M, et al. Among authors: orosz g. Eur J Pharmacol. 2001 Jun 1;421(1):61-7. doi: 10.1016/s0014-2999(01)01014-7. Eur J Pharmacol. 2001. PMID: 11408050

7

Side chain modifications change the binding and agonist properties of endomorphin 2.

Lengyel I, Orosz G, Biyashev D, Kocsis L, Al-Khrasani M, Rónai A, Tömböly C, Fürst Z, Tóth G, Borsodi A. Lengyel I, et al. Among authors: orosz g. Biochem Biophys Res Commun. 2002 Jan 11;290(1):153-61. doi: 10.1006/bbrc.2001.6136. Biochem Biophys Res Commun. 2002. PMID: 11779147

8

Engineering new peptidic inhibitors from a natural chymotrypsin inhibitor.

Mucsi Z, Perczel A, Orosz G. Mucsi Z, et al. Among authors: orosz g. J Pept Sci. 2002 Dec;8(12):643-55. doi: 10.1002/psc.423. J Pept Sci. 2002. PMID: 12523641

9

Irreversible labelling of the opioid receptors by a melphalan-substituted [Met5]enkephalin-Arg-Phe derivative.

Sartania N, Szatmári I, Orosz G, Rónai AZ, Medzihradszky K, Borsodi A, Benyhe S. Sartania N, et al. Among authors: orosz g. Eur J Pharmacol. 1999 Jun 4;373(2-3):241-9. doi: 10.1016/s0014-2999(99)00248-4. Eur J Pharmacol. 1999. PMID: 10414445

10

Structure-oriented rational design of chymotrypsin inhibitor models.

Mucsi Z, Gáspári Z, Orosz G, Perczel A. Mucsi Z, et al. Among authors: orosz g. Protein Eng. 2003 Sep;16(9):673-81. doi: 10.1093/protein/gzg090. Protein Eng. 2003. PMID: 14560053

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters